FRA · —
CY1K.F (CY1K.F) Stock
$3.03
-2.26%
FRA: CY1K.F
—
—
Valuation
Financials & Margins
Latest News
FDA approves ArkBio’s ziresovir for Phase II trial in severe RSV
Clinical Trials Arena · Aug 17, 2026
Empire Petroleum Marks Strategic Milestone With Successful 21,006-Foot Well in the Western Haynesville in Texas to Accelerate Revenue Development
Business Wire · Aug 17, 2026
Stock market today: Dow, S&P 500, Nasdaq futures waver ahead of retail earnings
Yahoo Finance · Aug 17, 2026
Transaction in Own Shares
GlobeNewswire · Aug 17, 2026
FDA grants fast track status to Phanes’ spevatamig for advanced BTC
Hospital Management · Aug 17, 2026
Valuation & Return Ratios
Peer Comparison
About CY1K.F
—
over the past 52 weeks the stock has ranged between $2.86 and $8.65, and currently trades 65.0% below its 52-week high.